phenylalanine has been researched along with Astrocytoma, Grade IV in 47 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (21.28) | 18.2507 |
2000's | 20 (42.55) | 29.6817 |
2010's | 14 (29.79) | 24.3611 |
2020's | 3 (6.38) | 2.80 |
Authors | Studies |
---|---|
Bennet, KE; Castellanos, M; Chang, SY; Chantigian, S; Guerrero, J; Manciu, FS; Manciu, M; Martinez Lopez, LV; Rahman, M | 1 |
Aldossari, S; Lockyer, NP; McMahon, G; Moore, KL | 1 |
Alamón, C; Cabral, P; Cerecetto, H; Couto, M; Dagrosa, MA; Nievas, S; Perona, M; Teixidor, F; Viñas, C | 1 |
Fukuda, H; Hiratsuka, J | 1 |
Adams, DJ; Bansal, V; Kulhari, H; Pooja, D; Shukla, R; Sistla, R; Telukutla, SR | 1 |
Anbai, A; Harada, T; Hashimoto, M; Hirose, K; Sato, M; Takai, Y; Wada, Y; Watanabe, T | 1 |
Arai, Y; Fujii, H; Honda, N; Itami, J; Kawai, K; Kurihara, H; Ohe, K; Yoshimoto, M | 1 |
Borrmann, N; Friedrich, S; Hedrich, HJ; Knapp, WH; Krauss, JK; Meyer, GJ; Nakamura, M; Schwabe, K; Walte, A | 1 |
Moss, RL; Sauerwein, WA; Wittig, A | 1 |
Kinashi, Y; Kitajima, E; Kubota, Y; Okayasu, R; Okumura, K; Ono, K; Takahashi, S | 1 |
Gabel, D; Sander, A; Wosniok, W | 1 |
Kageji, T; Kumada, H; Mizobuchi, Y; Nagahiro, S; Nakagawa, Y | 1 |
Ahmad, T; Barth, RF; Chandra, S; Kabalka, GW | 1 |
Imahori, Y; Kajimoto, Y; Kawabata, S; Kirihata, M; Kuroiwa, T; Miyashita, M; Miyatake, S; Ono, K; Otsuki, Y; Shibata, MA; Yokoyama, K | 1 |
H-Stenstam, B | 1 |
Inaji, M; Ishii, K; Ishiwata, K; Kimura, Y; Matsumura, A; Momose, T; Nariai, T; Ohno, K; Yamamoto, T | 1 |
Kumada, H; Matsuda, M; Matsumura, A; Nakai, K; Shirakawa, M; Tsurubuchi, T; Yamamoto, T | 1 |
Doi, A; Hiramatsu, R; Iida, K; Imahori, Y; Kawabata, S; Kirihata, M; Kumada, H; Kuroda, Y; Kuroiwa, T; Maruhashi, A; Masunaga, S; Michiue, H; Miyata, S; Miyatake, S; Nonoguchi, N; Ono, K; Sakurai, Y; Suzuki, M; Yokoyama, K | 1 |
Cheng, X; Guo, G; Jiang, X; Mao, X; Wang, P; Zhang, W; Zhang, X; Zhen, H | 1 |
Blass, G; Israel, I; Reiners, C; Samnick, S | 1 |
Chen, YW; Chou, FI; Lin, YL; Wong, TT; Yang, FY; Yen, SH | 1 |
Dießl, S; Flentje, M; Hänscheid, H; Israel, I; Löhr, M; Reiners, C; Samnick, S; Sweeney, R; Verburg, FA; Vince, GH | 1 |
Chandra, S; Coderre, JA; Kabalka, GW; Lorey, DR; Smith, DR | 1 |
Kabalka, GW; Khan, MK; Miller, LF; Nichols, TL; Smith, GT | 1 |
Allen, GC; Brooke, SL; Day, JC; Heard, PJ; Oyedepo, AC; Patel, H | 1 |
Binns, PJ; Coderre, JA; Harling, OK; Hopewell, JW; Kiger, WS; Riley, KJ; Turcotte, JC | 1 |
Capala, J; Dahlström, M; Lindström, A; Lindström, P; Wasteson, A | 1 |
Bergenheim, AT; Capala, J; Henriksson, R; Roslin, M | 1 |
Brun, A; H-Stenstam, B; Pellettieri, L; Rezaei, A; Sköld, K | 1 |
Brandau, W; Farmakis, G; Israel, I; Samnick, S | 1 |
Barth, RF; Chandra, S; Lorey, DR; Tjarks, W | 1 |
Bergenheim, AT; Blomquist, E; Capala, J; Franzén, L; Henriksson, R; Lindahl, SA; Michanek, A; Salford, LG; Westlin, JE | 1 |
Flam, F | 1 |
Bergland, R; Capala, J; Chadha, M; Chanana, AD; Coderre, JA; Elowitz, EH; Joel, DD; Liu, HB; Slatkin, DN | 1 |
Buonocore, E; Dyke, JP; Hübner, KF; Kabalka, GW; Longford, CP; Reddy, NK; Reid, WS; Roberts, TG; Smith, GT | 1 |
Bailey, SF; Fuhr, JE; Kabalka, GW | 1 |
Chadha, M; Chanana, AD; Coderre, JA; Elowitz, EH; Gebbers, JO; Joel, DD; Micca, PL; Nawrocky, MM; Peress, NS; Shady, M; Slatkin, DN | 1 |
Fujii, R; Ido, T; Imahori, Y; Kusuki, T; Ohmori, Y; Ono, K; Ueda, S | 1 |
Bergland, RM; Chadha, M; Chanana, AD; Coderre, JA; Elowitz, EH; Joel, DD | 1 |
Capala, J; Chadha, M; Chanana, AD; Coderre, JA; Elowitz, EH; Iwai, J; Joel, DD; Liu, HB; Wielopolski, L | 1 |
Coderre, JA; Joel, DD; Micca, PL; Nawrocky, MM | 1 |
Aziz, T; Capala, J; Chanana, A; Diaz, A; Peress, NS | 1 |
Feiden, W; Heimann, A; Kempski, O; Kirsch, CM; Richter, S; Romeike, BF; Samnick, S | 1 |
Busse, PM; Kiger, WS; Palmer, MR; Riley, KJ; Zamenhof, RG | 1 |
Bader, JB; Feiden, W; Hellwig, D; Kirsch, CM; Moringlane, JR; Romeike, BF; Samnick, S | 1 |
Chandra, S; Lorey II, DR; Smith, DR | 1 |
Barth, RF; Fairchild, RG; Soloway, AH | 1 |
1 review(s) available for phenylalanine and Astrocytoma, Grade IV
Article | Year |
---|---|
Pharmacokinetics of
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Glioblastoma; Humans; Isotopes; Melanoma; Neoplasms; Phenylalanine; Positron-Emission Tomography | 2020 |
8 trial(s) available for phenylalanine and Astrocytoma, Grade IV
Article | Year |
---|---|
Case numbers for a randomized clinical trial of boron neutron capture therapy for Glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Female; Germany; Glioblastoma; Humans; Male; Middle Aged; Phenylalanine; Prevalence; Risk Factors; Survival Rate; Temozolomide; Treatment Outcome | 2014 |
Correlation between radiation dose and histopathological findings in patients with gliblastoma treated with boron neutron capture therapy (BNCT).
Topics: Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Glioblastoma; Humans; Neoplasm, Residual; Phenylalanine; Radiotherapy Dosage; Statistics as Topic; Sulfhydryl Compounds; Survival Rate; Treatment Outcome | 2014 |
Tolerance of normal human brain to boron neutron capture therapy.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Disorders of Excessive Somnolence; Glioblastoma; Humans; Melanoma; Phenylalanine; Radiation Tolerance | 2004 |
Neuropathological postmortem evaluation of BNCT for GBM.
Topics: Aged; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Follow-Up Studies; Glioblastoma; Humans; Middle Aged; Phenylalanine; Radiotherapy Dosage; Treatment Outcome | 2007 |
Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Topics: Adult; Aged; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Fructose; Glioblastoma; Humans; Male; Middle Aged; Phenylalanine; Quality of Life; Survival Rate; Treatment Outcome | 2008 |
Boron neutron capture therapy for glioblastoma multiforme using p-boronophenylalanine and epithermal neutrons: trial design and early clinical results.
Topics: Adult; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Glioblastoma; Humans; Magnetic Resonance Imaging; Neutrons; Nuclear Reactors; Phenylalanine; Tissue Distribution | 1997 |
Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Topics: Aged; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Dose-Response Relationship, Radiation; Feasibility Studies; Glioblastoma; Humans; Middle Aged; Phenylalanine; Radiation-Sensitizing Agents; Radiotherapy Dosage; Treatment Outcome | 1998 |
A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans.
Topics: Adult; Aged; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Fructose; Glioblastoma; Humans; Infusions, Intravenous; Male; Melanoma; Middle Aged; Models, Biological; Phenylalanine; Skin Neoplasms | 2001 |
38 other study(ies) available for phenylalanine and Astrocytoma, Grade IV
Article | Year |
---|---|
Assessing Nordihydroguaiaretic Acid Therapeutic Effect for Glioblastoma Multiforme.
Topics: Antioxidants; Glioblastoma; Humans; Masoprocol; Phenylalanine; Reactive Oxygen Species | 2022 |
Microdistribution and quantification of the boron neutron capture therapy drug BPA in primary cell cultures of human glioblastoma tumour by NanoSIMS.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Intracellular Space; Mass Spectrometry; Molecular Imaging; Nanotechnology; Phenylalanine | 2019 |
Bimodal Therapeutic Agents Against Glioblastoma, One of the Most Lethal Forms of Cancer.
Topics: Animals; Antineoplastic Agents; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Glioblastoma; Humans; Mice; Pharmaceutical Preparations; Phenylalanine | 2020 |
Peptide grafted and self-assembled poly(γ-glutamic acid)-phenylalanine nanoparticles targeting camptothecin to glioma.
Topics: Antineoplastic Agents, Phytogenic; Brain; Brain Neoplasms; Camptothecin; Cell Line, Tumor; Drug Delivery Systems; Glioblastoma; Humans; Nanoconjugates; Peptides, Cyclic; Phenylalanine; Polyglutamic Acid | 2017 |
Impact of oxygen status on 10B-BPA uptake into human glioblastoma cells, referring to significance in boron neutron capture therapy.
Topics: Adaptor Proteins, Signal Transducing; Boron Compounds; Boron Neutron Capture Therapy; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Large Neutral Amino Acid-Transporter 1; Oxygen; Phenylalanine; RNA, Messenger | 2018 |
Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells.
Topics: Amino Acid Transport Systems; Biological Transport; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Methionine; Phenylalanine; Positron-Emission Tomography | 2013 |
Systemic treatment with 4-211Atphenylalanine enhances survival of rats with intracranial glioblastoma.
Topics: Animals; Astatine; Brachytherapy; Brain Neoplasms; Cell Line, Tumor; Dose-Response Relationship, Radiation; Female; Glioblastoma; Phenylalanine; Radiopharmaceuticals; Rats; Survival Rate; Treatment Outcome | 2013 |
Glioblastoma, brain metastases and soft tissue sarcoma of extremities: candidate tumors for BNCT.
Topics: Animals; Borohydrides; Boron Compounds; Brain Neoplasms; Cell Line, Tumor; Extremities; Glioblastoma; Humans; Male; Mice; Mice, Nude; Phenylalanine; Radiotherapy Dosage; Sarcoma; Sulfhydryl Compounds; Tissue Distribution | 2014 |
Dose-rate effect was observed in T98G glioma cells following BNCT.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Cell Survival; CHO Cells; Cricetinae; Cricetulus; DNA Damage; Dose-Response Relationship, Radiation; Glioblastoma; Humans; Phenylalanine; Radiotherapy Dosage; Treatment Outcome | 2014 |
Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Calcium; Cell Line, Tumor; Cell Tracking; Glioblastoma; Humans; Intracellular Space; Isotopes; Microscopy, Confocal; Phenylalanine; Potassium; Sodium; Spectrometry, Mass, Secondary Ion; Time Factors | 2014 |
Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas.
Topics: Boranes; Brain Neoplasms; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Magnetic Resonance Imaging; Phenylalanine; Positron-Emission Tomography; Retrospective Studies; Statistics, Nonparametric | 2008 |
Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
Topics: Adult; Aged; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Clinical Trials, Phase II as Topic; Female; Fructose; Glioblastoma; Humans; Male; Middle Aged; Phenylalanine; Quality of Life; Survival Rate; Treatment Outcome | 2008 |
PET pharmacokinetic analysis to estimate boron concentration in tumor and brain as a guide to plan BNCT for malignant cerebral glioma.
Topics: Algorithms; Astrocytoma; Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Carbon Radioisotopes; Glioblastoma; Glioma; Humans; Methionine; Phenylalanine; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiotherapy Planning, Computer-Assisted | 2009 |
Dose distribution and clinical response of glioblastoma treated with boron neutron capture therapy.
Topics: Adult; Aged; Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Phenylalanine; Photons; Radiotherapy Dosage; Retrospective Studies; Sulfhydryl Compounds; Survival Rate; Treatment Failure | 2009 |
Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Topics: Borohydrides; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Clinical Protocols; Combined Modality Therapy; Glioblastoma; Humans; Japan; Phenylalanine; Prognosis; Radiation-Sensitizing Agents; Sulfhydryl Compounds; Survival Rate | 2009 |
Boron neutron capture therapy induces apoptosis of glioma cells through Bcl-2/Bax.
Topics: Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Shape; Cell Survival; Cobalt Radioisotopes; Dose-Response Relationship, Radiation; Flow Cytometry; Gamma Rays; Glioblastoma; Humans; Microscopy, Electron, Transmission; Neutrons; Phenylalanine; Proto-Oncogene Proteins c-bcl-2; Radiation-Sensitizing Agents; Time Factors | 2010 |
Validation of an amino-acid-based radionuclide therapy plus external beam radiotherapy in heterotopic glioblastoma models.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Disease Models, Animal; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Phenylalanine; Radiotherapy; Rats; Transplantation, Heterotopic | 2011 |
Boron neutron capture therapy for glioblastoma multiforme: enhanced drug delivery and antitumor effect following blood-brain barrier disruption induced by focused ultrasound.
Topics: Animals; Blood-Brain Barrier; Boron Neutron Capture Therapy; Brain Neoplasms; Drug Delivery Systems; Glioblastoma; Humans; Phenylalanine; Rats; Sound; Tissue Distribution | 2012 |
Patients with recurrent glioblastoma multiforme. Initial experience with p-[(131)I]iodo-L-phenylalanine and external beam radiation therapy.
Topics: Adult; Aged; Brain Neoplasms; Female; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Phenylalanine; Pilot Projects; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy, Conformal; Treatment Outcome | 2013 |
Imaging of fluorine and boron from fluorinated boronophenylalanine in the same cell at organelle resolution by correlative ion microscopy and confocal laser scanning microscopy.
Topics: Boron; Boron Compounds; Brain Neoplasms; Fluorine; Glioblastoma; Humans; Image Processing, Computer-Assisted; Ions; Microscopy, Confocal; Mitochondria; Models, Chemical; Phenylalanine; Radiation-Sensitizing Agents; Time Factors; Tomography, Emission-Computed; Tumor Cells, Cultured | 2002 |
Improved treatment planning for boron neutron capture therapy for glioblastoma multiforme using fluorine-18 labeled boronophenylalanine and positron emission tomography.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Fluorine Radioisotopes; Glioblastoma; Humans; Magnetic Resonance Imaging; Necrosis; Neutrons; Phenylalanine; Radiometry; Radiotherapy Planning, Computer-Assisted; Time Factors; Tomography, Emission-Computed | 2002 |
Analysis of boron-10 in soft tissue by dynamic secondary ion mass spectrometry.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Disease Models, Animal; Glioblastoma; Gliosarcoma; Humans; Isotopes; Mice; Phenylalanine; Rats; Spectrometry, Mass, Secondary Ion; Tumor Cells, Cultured | 2004 |
Accumulation of boron in human malignant glioma cells in vitro is cell type dependent.
Topics: Boranes; Boron; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line; Cell Line, Tumor; Fibroblasts; Glioblastoma; Glioma; Humans; Phenylalanine | 2004 |
Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Topics: Blood Glucose; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Glioblastoma; Humans; Microdialysis; Phenylalanine; Radiation-Sensitizing Agents | 2005 |
Improved synthesis of no-carrier-added p-[124I]iodo-L-phenylalanine and p-[131I]iodo-L-phenylalanine for nuclear medicine applications in malignant gliomas.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Glioblastoma; Humans; Iodine Radioisotopes; Mice; Mice, Nude; Nuclear Medicine; Phenylalanine; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Specific Pathogen-Free Organisms; Tissue Distribution; Xenograft Model Antitumor Assays | 2008 |
Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Cell Line; Glioblastoma; Humans; Interphase; Mitosis; Phenylalanine; Spectrometry, Mass, Secondary Ion | 2008 |
Cancer treatment. Will history repeat for boron capture therapy?
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Clinical Trials as Topic; Glioblastoma; Humans; Japan; Phenylalanine; Radiation-Sensitizing Agents; United States | 1994 |
Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Female; Fluorine Radioisotopes; Fructose; Glioblastoma; Humans; Middle Aged; Phenylalanine; Radiation-Sensitizing Agents; Tomography, Emission-Computed | 1997 |
In vitro effects of boron-containing compounds upon glioblastoma cells.
Topics: Boron Compounds; Boron Neutron Capture Therapy; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA Replication; Flow Cytometry; Fluorine Radioisotopes; Fructose; Glioblastoma; Humans; Phenylalanine; Tumor Cells, Cultured | 1997 |
Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity.
Topics: Boron; Boron Compounds; Boron Neutron Capture Therapy; Glioblastoma; Humans; Phenylalanine; Tissue Distribution | 1998 |
Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma.
Topics: Astrocytoma; Boron Compounds; Brain Neoplasms; Cerebrovascular Circulation; Fluorine Radioisotopes; Glioblastoma; Glioma; Humans; Phenylalanine; Radiopharmaceuticals; Tomography, Emission-Computed | 1998 |
Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy.
Topics: Boron Compounds; Brain; Brain Neoplasms; Craniotomy; Glioblastoma; Humans; Injections, Intravenous; Neutron Capture Therapy; Osmolar Concentration; Phenylalanine; Radiation-Sensitizing Agents; Scalp; Tissue Distribution | 1998 |
Effect of dose and infusion time on the delivery of p-boronophenylalanine for neutron capture therapy.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Brain Neoplasms; Glioblastoma; Gliosarcoma; Infusions, Intravenous; Metabolic Clearance Rate; Phenylalanine; Radiation-Sensitizing Agents; Rats; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Postmortem neuropathological features secondary to boron neutron capture therapy for glioblastoma multiforme.
Topics: Adult; Aged; Boron Compounds; Boron Neutron Capture Therapy; Brain; Brain Neoplasms; Dose-Response Relationship, Radiation; Female; Glioblastoma; Humans; Lewy Bodies; Male; Middle Aged; Nerve Degeneration; Neurofibrillary Tangles; Neurons; Phenylalanine; Radiation-Sensitizing Agents | 2000 |
Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats.
Topics: Alanine; Amino Acids; Amino Acids, Cyclic; Animals; beta-Alanine; Binding, Competitive; Blood-Brain Barrier; Brain Neoplasms; Cysteine; Glioblastoma; Humans; Iodine Radioisotopes; Isoquinolines; Male; Methyltyrosines; Neoplasm Transplantation; Phenylalanine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Serine; Tetrahydroisoquinolines; Tomography, Emission-Computed, Single-Photon; Tumor Cells, Cultured | 2000 |
Initial evaluation of the feasibility of single photon emission tomography with p-[123 I]iodo-L-phenylalanine for routine brain tumour imaging.
Topics: Adult; Aged; Animals; Astrocytoma; Brain Neoplasms; Feasibility Studies; Female; Fluorodeoxyglucose F18; Glioblastoma; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Phenylalanine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Whole-Body Counting | 2002 |
Quantitative subcellular secondary ion mass spectrometry (SIMS) imaging of boron-10 and boron-11 isotopes in the same cell delivered by two combined BNCT drugs: in vitro studies on human glioblastoma T98G cells.
Topics: Borohydrides; Boron; Boron Compounds; Boron Neutron Capture Therapy; Cell Division; Cell Size; Glioblastoma; Humans; Organelles; Phenylalanine; Radioisotopes; Spectrometry, Mass, Secondary Ion; Sulfhydryl Compounds; Time Factors; Tumor Cells, Cultured | 2002 |
Boron neutron capture therapy for cancer.
Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Boron; Boron Compounds; Brain Neoplasms; Glioblastoma; Humans; Immunotoxins; Isotopes; Melanoma; Mice; Neoplasms; Neutrons; Phenylalanine; Radiation Dosage | 1990 |